Specialist Skin Formulary
Lancashire Medicines Management Board (ELMMB) for the product to be considered for inclusion in the formulary.
|Wherever possible the use of licensed medicines is encouraged to assure safety and efficacy. For many common dermatological
|diseases including psoriasis and eczema, the range of licensed medicines is limited. As a result, Dermatology prescribing may
|rely significantly on unlicensed creams and ointments (known as ‘Specials’) containing tars, dithranol, salicylic acid, steroids and
|other active constituents in a range of concentrations and bases. This is of particular concern in primary care where lack of
|effective price controls and a mechanism to ensure independent scrutiny of product quality has increased costs and concern
|To address these concerns and help to optimise quality of care Dermatology 'Specials' should only be prescribed from the
| 'Specials Recommended by the British Association of Dermatologists for Skin Disease'
|The prescribing of such products may be continued in Primary Care.
|When a product is required that is not included in the 'BAD' list then the prescribing of such will remain with the Consultant/ Prescriber and may not be continued in Primary Care.
|Where a preparation is required that is not listed in the BAD document then there is a requirement to submit a request to East
All material in this section is aimed at health care professionals, but is information currently held in the public domain, members of the
public seeking advice on medicine-related matters are advised to speak with their GP, pharmacist, nurse or contact NHS111 Service.
| Email: email@example.com
| Copyright© 2016 East Lancashire Medicines Management Board.
| All rights reserved. Disclaimer/Terms and conditions